Michael W. Bonney

Bonney is currently executive chair of the board of Kaleido Buiosciences Inc., having served as CEO and chairman until 2018. Previously, he was a partner of Third Rock Ventures LLC, and was president and CEO of Cubist Pharmaceuticals Inc. He held executive positions at Biogen Inc. from 1995 to 2001 and was with Zeneca Pharmaceuticals for 11 years.

  • 2019 Fourth Quarter

Added to: Bristol-Myers Squibb Co. - New York, NY

Bristol-Myers is a biopharmaceutical company. Revenues are $47 billion.